Hundreds of clinics may be guilty of false or misleading claims in ketamine advertising

Hundreds of clinics may be using false and misleading statements in online advertising campaigns by offering off-label and unapproved ketamine to treat a variety of mental health and pain conditions, according to researchers at the University of Colorado Anschutz Medical Campus and Johns Hopkins University.

Leave A Comment

Your email address will not be published. Required fields are marked *